Literature DB >> 11561113

Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis.

B A Rajasekaran1, D Shovlin, P Lord, C A Kelly.   

Abstract

OBJECTIVES: There is a lack of information on the natural history of patients with rheumatoid arthritis (RA) and associated interstitial lung disease (ILD). However, cryptogenic fibrosing alveolitis (CFA) is known to have a poor long-term prognosis. As part of a longitudinal prospective study, we compared baseline characteristics in 18 patients with RA-ILD and 18 patients with CFA matched for age, sex and symptoms. We wished to establish whether there were significant baseline differences in clinical, physiological or radiological parameters.
METHODS: A diagnosis of ILD was confirmed by high-resolution computed tomography (HRCT) and supported by clinical and physiological findings in all patients. A number of clinical, immunological, physiological and radiological parameters were compared between the two groups. The median age in each group was 77 yr and 10 patients in each group were male.
RESULTS: Twelve of the RA patients had smoked in excess of 10 pack yr as compared with nine patients with CFA (not significant). Clubbing was found in five patients with RA-ILD and in 14 with CFA (P=0.008). Pulmonary function tests showed no significant differences between the groups in forced expiratory volume in 1s, vital capacity or gas transfer factor. HRCT showed more ground glass shadowing and peripheral disease in RA patients, but more established basal disease in those with CFA. Additionally, HRCT evidence of honeycombing was associated with an absence of rheumatoid factor and a low gas transfer factor.
CONCLUSIONS: Clubbing is more common in patients with CFA, while RA-ILD patients have a higher prevalence of rheumatoid factor. Together with the differences in baseline HRCT, these variables in two groups of patients with similar physiological impairment at baseline may be important predictors of outcome in the longer term.

Entities:  

Mesh:

Year:  2001        PMID: 11561113     DOI: 10.1093/rheumatology/40.9.1022

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  12 in total

Review 1.  Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients.

Authors:  Riccardo Messina; Giuliana Guggino; Alida Benfante; Nicola Scichilone
Journal:  Drugs Aging       Date:  2020-01       Impact factor: 3.923

2.  Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms.

Authors:  F Figen Ayhan-Ardic; Oznur Oken; Z Rezan Yorgancioglu; Nilgun Ustun; F Dilek Gokharman
Journal:  Clin Rheumatol       Date:  2005-08-10       Impact factor: 2.980

3.  Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis.

Authors:  J K Dawson; H E Fewins; J Desmond; M P Lynch; D R Graham
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

4.  Spectrum of diffuse parenchymal lung diseases with special reference to idiopathic pulmonary fibrosis and connective tissue disease: An eastern India experience.

Authors:  Somenath Kundu; Subhra Mitra; Joydeep Ganguly; Subhasis Mukherjee; Souvik Ray; Ritabrata Mitra
Journal:  Lung India       Date:  2014-10

5.  Decline of Pulmonary Function Is Associated With the Presence of Rheumatoid Factor in Korean Health Screening Subjects Without Clinically Apparent Lung Disease: A Cross-Sectional Study.

Authors:  Jiwon Hwang; Jae-Uk Song; Joong Kyong Ahn
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

Review 6.  Rheumatoid arthritis-associated interstitial lung disease.

Authors:  Joshua J Solomon; Kevin K Brown
Journal:  Open Access Rheumatol       Date:  2012-03-05

7.  The challenges in classifying rheumatoid arthritis-associated interstitial lung disease.

Authors:  Hanna Nurmi; Riitta Kaarteenaho
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 2.895

8.  RA-ILD: does more detailed radiological classification add something to our knowledge of this condition?

Authors:  Paola Faverio; Meena Kalluri; Fabrizio Luppi; Giovanni Ferrara
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 2.895

9.  Digital Clubbing Is Associated with Higher Serum KL-6 Levels and Lower Pulmonary Function in Patients with Interstitial Lung Disease.

Authors:  Kazushige Shiraishi; Torahiko Jinta; Naoki Nishimura; Hiroshi Nakaoka; Ryosuke Tsugitomi; Kohei Okafuji; Atsushi Kitamura; Yutaka Tomishima; Gautam A Deshpande; Tomohide Tamura
Journal:  Can Respir J       Date:  2018-01-23       Impact factor: 2.409

10.  Predicting outcomes in rheumatoid arthritis related interstitial lung disease.

Authors:  Joseph Jacob; Nikhil Hirani; Coline H M van Moorsel; Srinivasan Rajagopalan; John T Murchison; Hendrik W van Es; Brian J Bartholmai; Frouke T van Beek; Marjolijn H L Struik; Gareth A Stewart; Maria Kokosi; Ryoko Egashira; Anne Laure Brun; Gary Cross; Joseph Barnett; Anand Devaraj; George Margaritopoulos; Ronald Karwoski; Elisabetta Renzoni; Toby M Maher; Athol U Wells
Journal:  Eur Respir J       Date:  2019-01-03       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.